Psilocybin mushrooms, a traditional psychedelic akin to LSD due to their role as a serotonin 5-HT2A receptor agonist, are currently under research for psilocybin-assisted therapy. This therapy targets mental health disorders such as major depression, anxiety, emotional distress, cluster headaches, and migraines.
It is essential to delve into how shrooms metabolize in the body to understand their therapeutic effects on these conditions. This knowledge enables researchers and users to gauge the psychological and therapeutic impacts of the active compound. This article offers a basic understanding of psilocybin’s pharmacology and pharmacokinetics.
[toc]
Key Takeaways:
- 50% of the ingested psychedelic fungi is absorbed and spread throughout the body.
- The fungi’s compound is dephosphorylated by the enzyme alkaline phosphatase, mainly in the liver.
- Approximately 3.4% of the compound is expelled in its original form within a day, with the remainder being discharged as a stable metabolite.
What is Pharmacokinetics?
Pharmacokinetics (PK) is an area of study that focuses on the body’s handling of substances such as drugs after they’ve been ingested. It’s closely related to pharmacodynamics, which explores how a compound interacts with the body. PK primarily investigates four aspects: absorption, distribution, metabolism, and excretion (ADME).
Understanding these processes equips healthcare providers with the ability to prescribe the most effective medications with the least risk. It also aids them in customizing treatments to suit each patient’s specific physiology and lifestyle.
Pharmacokinetics and its Relevance to Psilocybin?
Psilocybin and psilocin, the primary active compounds in certain magic mushroom species, have garnered significant attention from researchers and users. Pharmacokinetics studies how the body processes these mushrooms, thus shedding light on their potential medicinal or recreational impacts.
These compounds are referred to by various names, such as “magic,” “psychedelic,” “medicinal,” or “sacred.” The fungi containing these compounds are ingested, and The mushroom species, their origins, sizes, the conditions in which they grow and are dried, as well as their age, can all contribute to substantial differences in their potency levels.
Although these mushrooms naturally occur in the wild, scientists have now developed ways to synthesize them in a laboratory setting. Both the natural and synthetic versions are characterized by low toxicity, but they may cause minor side effects such as nausea or vomiting.
Despite these physical side effects, the compounds found in these mushrooms have demonstrated potential therapeutic benefits due to their safety profile and their non-addictive nature. These benefits have encouraged researchers to explore their usage in psychotherapy, in particular, as a treatment for anxiety and depression.
The 4 Phases of Pharmacokinetics
Psilocybin, the compound present in these mushrooms, is inactive in its original state and functions as a prodrug, converting into its active form, psilocin. This transformation is facilitated by enzymes such as alkaline phosphatase, which enable psilocin to be absorbed and circulated throughout the body, reaching different tissues. However, psilocybin cannot be detected in the circulatory system, feces, or urine after it has been orally administered.
Absorption
Absorption is the process by which the compound enters the bloodstream from the site of its administration. This process determines the speed and effectiveness with which the compound reaches its target, such as the plasma. Oral administration is the most commonly used method. While inhalation has been tried, it is not as efficient as oral consumption.
The absorption process also includes the release of the compound from the dosage form during oral ingestion. Factors such as delays in the throat or esophagus can influence this, potentially slowing down effectiveness or causing irritation. Once the compound reaches the stomach, the acidic environment may start to break it down before it is absorbed into the bloodstream.
Studies conducted on animals indicate that only around 50% of orally administered psychedelics are absorbed and distributed throughout the body.
Factors Affecting the Absorption Process
Various factors can affect the absorption process, leading to differences in the onset, intensity, and duration of effects:
- Stomach Contents: Having a full stomach can slow down the process as it delays the onset of effects. Conversely, an empty stomach allows for quicker absorption.
- Body Fat: Compounds may accumulate in adipose tissues, potentially prolonging their effects.
- Age: Metabolic rates and body composition may change with age.
- Zero-Order Kinetics: The substance is eliminated at a constant rate, regardless of its concentration.
- First-Order Kinetics: The elimination rate is proportional to the concentration of the drug.
Dissemination refers to how psilocin disperses within the body after entering the bloodstream. As a lipophilic substance, psilocin can traverse the blood-brain barrier to access the central nervous system.
Various factors, including the substance’s size, polarity, and protein-binding capacity, as well as an individual’s physiological state—encompassing hydration status and body composition—significantly influence this process.
The goal is to achieve an effective concentration at the intended site. For the substance to be effective, it must arrive at the specific area, as defined by the volume of distribution, and remain unbound to proteins, allowing it to actively engage with its receptor.
What Factors Impact the Dissemination Processes?
Several factors can impact the dissemination process:
Effects typically begin to manifest around 20-40 minutes after ingestion, peaking around 80-100 minutes. The effects of magic mushrooms generally last for about 4-6 hours.
How is Dissemination to the Brain Achieved?
Initial experimental research on two species found that the binding affinity sequence is 5HT2A > 5HT1A > 5HT2B [23]. It also binds to dopamine D1, 5HT1E, 5HT5A, 5HT7, 5HT6, D3, 5HT2C, and 5HT1B receptors.
It acts as a partial agonist at the 5HT2A receptor, with an efficacy of about 40%. The psychedelic effects can be traced back to its partial agonist activity at 5HT1A autoreceptors.
The mood-elevating and psychotomimetic experiences may be tied to the identified correlation between increased dopamine levels and feelings of depersonalization and euphoria. Hallucinogens work by modifying neurochemistry and receptor activity. It enhances 5HT2A agonist activity by promoting BDNF synthesis in the hippocampus, which subsequently fosters neurogenesis and lessens conditioned fear-related behaviors.
Elimination
Elimination involves the process by which the
The human body expels substances primarily through the kidneys, but also via other pathways such as the lungs, skin, or gastrointestinal tract. In the context of the kidneys, they filter or secrete a naturally occurring psychedelic drug in the glomerulus or tubules, a process complicated by some reabsorption.
The primary compound has an average half-life of about 160 minutes, whereas psilocin’s half-life is roughly 50 minutes. Animal studies indicate that the majority of this is expelled through urine, making up about 65% within 8 hours. Even after consumption, small amounts of the substance can be detected in bile and feces.
In humans, nearly 3.4% of the substance is excreted in its unaltered form within 24 hours, while most is eliminated as psilocin-O-glucuronide, a more durable metabolite. This stability allows the compound to be identified in urine samples over a longer duration.
There are primarily two methods for substance elimination:
Most psychedelic substances adhere to the first-order kinetics method, reaching equilibrium concentrations after four to five half-lives. Complete removal also occurs after about four to five half-lives.
Discover Our Variety of Psychedelic Mushrooms
The metabolic process can differ between various types of fungi. By buying from reliable online vendors like Magic Mushrooms Online Canada, you can avoid the risk of consuming poisonous mushrooms. Some types, such as Agaric mushrooms, may induce intense and unpleasant effects. Hence, it’s essential to procure magic mushrooms from trusted dispensaries instead of unreliable street vendors or wild foraging.
| Feature | Enigma | Full Moon Party | Gold Member | |
| Strain Type | Psilocybe Cubensis OMNI | Psilocybe cubensis (Thai Koh Samui) | Psilocybe cubensis | |
| Potency | Extremely high; 3.8% tryptamine content | Moderate to high potency | High potency | |
| Visual Characteristics | Takes the form of a blob or | Resembles a cauliflower or a brain in structure | Exhibits the standard appearance of a cubensis; of average size | Thick, white stems; caps are a golden caramel color; noticeable blue bruising can occur |
| Effects | Considered the most potent; generates intense effects | Produces a powerful mental high; onset is delayed with significant visuals | Produces significant visuals and a sense of euphoria |
Understanding Psilocybin Mushroom Usage Online
For medical professionals, researchers, and users alike, gaining a deep understanding of the pharmacokinetics of shrooms is crucial. Such knowledge empowers you to make informed decisions about dosage and timing, consequently reducing potential risks.
Discover your perfect psychedelic experience at Magic Mushrooms Online Canada. Whether you’re in search of a tranquil journey or a deeper exploration, our extensive product line is tailored to meet your unique needs. Enjoy premium, safe, and quality-controlled shrooms, eradicating worries about unreliable sources or poisonous mushrooms.
Indulge in the best magic mushrooms Canada has to offer and elevate your psychedelic journey to new heights.
Frequently Asked Questions
Are there any confirmed interactions between shrooms and other drugs?
Our products may interact with certain drugs, especially those affecting serotonin levels, such as SSRIs (Selective Serotonin Reuptake Inhibitors). SSRIs and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) usually reduce the effects, unlike non-serotonergic antidepressants. This reduced effect can last for up to three months after discontinuing the antidepressant usage.
Do all psychedelics activate the same pathway as psilocybin?
No, each psychedelic substance has a unique structure that requires different metabolic processes to activate, and they attach to various receptors within the body. The mode of administration also affects each psychedelic’s absorption. While the basic principles of absorption, metabolism, and distribution are the same, the specific pathways and effects vary for each substance.
Does the form of the shroom affect the pharmacokinetics?
Yes, the form (whether fresh, powdered, or dried mushrooms) can influence the absorption rate. For example, powdered forms might be absorbed faster than whole dried ones due to quicker dissolution.
Suggested Reads:
